Nature Communications (Mar 2019)

Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT

  • Maddalena Noviello,
  • Francesco Manfredi,
  • Eliana Ruggiero,
  • Tommaso Perini,
  • Giacomo Oliveira,
  • Filippo Cortesi,
  • Pantaleo De Simone,
  • Cristina Toffalori,
  • Valentina Gambacorta,
  • Raffaella Greco,
  • Jacopo Peccatori,
  • Monica Casucci,
  • Giulia Casorati,
  • Paolo Dellabona,
  • Masahiro Onozawa,
  • Takanori Teshima,
  • Marieke Griffioen,
  • Constantijn J. M. Halkes,
  • J. H. F. Falkenburg,
  • Friedrich Stölzel,
  • Heidi Altmann,
  • Martin Bornhäuser,
  • Miguel Waterhouse,
  • Robert Zeiser,
  • Jürgen Finke,
  • Nicoletta Cieri,
  • Attilio Bondanza,
  • Luca Vago,
  • Fabio Ciceri,
  • Chiara Bonini

DOI
https://doi.org/10.1038/s41467-019-08871-1
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 15

Abstract

Read online

Allogeneic hematopoietic cell transplantation is the standard treatment of acute myeloid leukemia, but many patients relapse. Here the authors show increased markers of exhaustion and cancer antigen specificity within bone marrow-residing memory T cells precede and potentially predict the relapse.